Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients. [electronic resource]
Producer: 20140117Description: 1060-7 p. digitalISSN:- 1468-1331
- Adjuvants, Immunologic -- therapeutic use
- Adolescent
- Adult
- Aged
- Drug Resistance
- Female
- Glatiramer Acetate
- Humans
- Interferon-beta -- therapeutic use
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Neuroimaging
- Peptides -- therapeutic use
- Retrospective Studies
- Risk Factors
- Secondary Prevention
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.